477 results on '"Williams, Simon G."'
Search Results
2. Impact of Myocardial Fibrosis on Cardiovascular Structure, Function and Functional Status in Heart Failure with Preserved Ejection Fraction
3. Phenogrouping heart failure with preserved or mildly reduced ejection fraction using electronic health record data
4. Abstract 18657: Diagnostic Yield of Whole Genome Sequencing in Congenital Heart Disease: Data From the UK 100,000 Genomes Project
5. Predictors of myocardial fibrosis and response to anti-fibrotic therapy in heart failure with preserved ejection fraction
6. Joint analysis of functionally related genes yields further candidates associated with Tetralogy of Fallot
7. FLT4 causes developmental disorders of the cardiovascular and lymphovascular systems via pleiotropic molecular mechanisms
8. Significantly increased risk of chronic obstructive pulmonary disease amongst adults with predominantly mild congenital heart disease
9. Predicting hospitalisation for heart failure and death in patients with, or at risk of, heart failure before first hospitalisation: a retrospective model development and external validation study
10. Rare variants in KDR, encoding VEGF Receptor 2, are associated with tetralogy of Fallot
11. Clinical risk associated with COVID-19 among 86000 patients with congenital heart disease
12. Rare GATA6 variants associated with risk of congenital heart disease phenotypes in 200,000 UK Biobank exomes
13. Pirfenidone in heart failure with preserved ejection fraction: a randomized phase 2 trial
14. The utility of cardiovascular imaging in heart failure with preserved ejection fraction: diagnosis, biological classification and risk stratification
15. Identification of heart failure hospitalization from NHS Digital data: comparison with expert adjudication.
16. A novel RNA-mediated mechanism causing down-regulation of insulating promoter interactions in human embryonic stem cells
17. Association of congenital cardiovascular malformation and neuropsychiatric phenotypes with 15q11.2 (BP1–BP2) deletion in the UK Biobank
18. Growth differentiation factor-15 in patients with or at risk of heart failure but before first hospitalisation.
19. Growth differentiation factor-15 in patients with or at risk of heart failure but before first hospitalisation
20. Pirfenidone in Heart Failure with Preserved Ejection Fraction—Rationale and Design of the PIROUETTE Trial
21. Treatment Adherence in a Randomized Controlled Trial of Pirfenidone in HFpEF: Determinants and Impact on Efficacy
22. The clinical application of cardiac functional reserve estimation in patients with chronic heart failure and coronary artery disease
23. Whole Exome Sequencing Reveals the Major Genetic Contributors to Nonsyndromic Tetralogy of Fallot
24. Author Correction: Promoter interactome of human embryonic stem cell-derived cardiomyocytes connects GWAS regions to cardiac gene networks
25. Characteristics Associated With Growth Differentiation Factor 15 in Heart Failure With Preserved Ejection Fraction and the Impact of Pirfenidone
26. Promoter interactome of human embryonic stem cell-derived cardiomyocytes connects GWAS regions to cardiac gene networks
27. Deletion of 19q13 reveals clinical overlap with Dubowitz syndrome
28. Cardiogenic Shock : Physiological and Biochemical Concepts
29. Myocardial recovery with mechanical circulatory support
30. The renin-angiotensin-aldosterone system in heart failure for the non-specialist: the past, the present and the future
31. Agnathia-otocephaly complex and asymmetric velopharyngeal insufficiency due to an in-frame duplication in OTX2
32. Impact of Myocardial Fibrosis on Cardiovascular Structure, Function and Functional Status in Heart Failure With Preserved Ejection Fraction
33. Correction to: Rare variants in KDR, encoding VEGF Receptor 2, are associated with tetralogy of Fallot (Genetics in Medicine, (2021), 23, 10, (1952-1960), 10.1038/s41436-021-01212-y)
34. Bi-allelic variants in the mitochondrial RNase P subunit PRORP cause mitochondrial tRNA processing defects and pleiotropic multisystem presentations
35. 7 Predictors of myocardial fibrosis and response to anti-fibrotic therapy in heart failure with preserved ejection fraction
36. Rare GATA6 variants associated with risk of congenital heart disease phenotypes in 200,000 UK Biobank exomes
37. Impaired Glucose Tolerance and Insulin Resistance in Heart Failure: Underrecognized and Undertreated?
38. Clinical Genetic Risk Variants Inform a Functional Protein Interaction Network for Tetralogy of Fallot
39. Is Foxglove Effective in Heart Failure?
40. The transfemoral approach for cardiac resynchronization therapy
41. The Immune System and Chronic Heart Failure: Is the Heart in Control?
42. Rationale and study design of the REM-HF study: remote management of heart failure using implanted devices and formalized follow-up procedures
43. The development of left ventricular torsion and its clinical relevance
44. Updated NICE guidance on secondary prevention post-MI
45. Histological validation of dynamic-equilibrium cardiovascular magnetic resonance for the measurement of myocardial extracellular volume
46. Heritability and family-based GWAS analyses of the N-acyl ethanolamine and ceramide plasma lipidome
47. Heritability and family-based GWAS analyses of the N-acyl ethanolamine and ceramide lipidome reveal genetic influence over circulating lipids
48. Diagnosis of acute cardiac allograft rejection using cardiovascular magnetic resonance - preliminary findings
49. The utility of cardiovascular imaging in heart failure with preserved ejection fraction: diagnosis, biological classification and risk stratification
50. How do different indicators of cardiac pump function impact upon the long-term prognosis of patients with chronic heart failure?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.